Neuphoria Therapeutics Inc. Form DEFC14A: Definitive proxy statement in a contested solicitation
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-11-24: Form DEFC14A; Description DEFC14A; Document d16936ddefc14a.htm.
- 2025-11-24: Form DEFC14A; Description DEFC14A; Document ny20058725x4_defc14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-11-24 | DEFC14A | DEFC14A | d16936ddefc14a.htm | |
| 2025-11-24 | DEFC14A | DEFC14A | ny20058725x4_defc14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |